ITC Seeks Public Comment on Melanoma Test Patent Complaint
July 15, 2026
July 15, 2026
WASHINGTON, July 15 (TNSFR) -- The International Trade Commission is seeking public comments after receiving a Section 337 complaint from Castle Biosciences Inc., Friendswood, Texas, alleging patent violations involving imported melanoma predictive and prognostic tests and requesting trade remedies against four respondents.
The complaint, filed on July 10, alleges violations of Section 337 of the Tariff Act of 1930 involving the importation, sale for importation and sale in the U.S. . . .
The complaint, filed on July 10, alleges violations of Section 337 of the Tariff Act of 1930 involving the importation, sale for importation and sale in the U.S. . . .